X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
UNICHEM LABORATORIES LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

UNICHEM LABORATORIES LIMITED  (UNCHM)


Here is the latest financial fact sheet of Unichem Lab. For more details, see the Unichem Lab quarterly results and Unichem Lab share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
unichem lab - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 274.3       No. of shares m 90.70
    Mkt Cap Rs m 24,874       % ch % 0.4
    Vol '000 8.8       % ch week % -4.6
    P/E X 24.7       % ch 1-mth % 10.0
    P/CF X 16.9       % ch 12-mth % 25.4
    EPS (TTM) Rs 11.1       52 week H/L Rs 319.9/218.0
(As on Mar 28, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs224217237268334 
Low Rs101124138182174 
Sales per share (Unadj.) Rs96.9119.5125.1132.4146.9 
Earnings per share (Unadj.) Rs7.912.518.78.311.9 
Diluted earnings per shareRs7.912.518.78.311.9 
Cash flow per share (Unadj.) Rs11.316.823.712.916.2 
Dividends per share (Unadj.) Rs3.004.508.002.002.00 
Adj. dividends per shareRs2.994.497.992.002.00 
Dividend yield (eoy) %1.82.64.30.90.8 
Book value per share (Unadj.) Rs73.180.490.195.6105.1 
Adj. book value per shareRs72.880.290.095.6105.3 
Shares outstanding (eoy) m90.3290.4690.6390.7790.84 
Bonus/Rights/Conversions  ESOPESOP--ESOP 
Price / Sales ratio x1.71.41.51.71.7 
Avg P/E ratio x20.613.610.027.121.4 
P/CF ratio (eoy) x14.410.27.917.515.7 
Price / Book Value ratio x2.22.12.12.42.4 
Dividend payout %38.036.042.824.116.8 
Avg Mkt Cap Rs m14,67715,42316,99320,41923,073 
No. of employees `0004.04.65.15.55.7 
Total wages/salary Rs m1,4011,6491,8742,2322,558 
Avg. sales/employee Rs Th2,188.72,353.72,208.22,181.52,352.5 
Avg. wages/employee Rs Th350.2359.1365.0405.2450.9 
Avg. net profit/employee Rs Th178.2246.6329.9136.8190.4 
  INCOME DATA
Net Sales Rs m8,75510,80811,33512,01813,346 
Other income Rs m102134423204192 
Total revenues Rs m8,85710,94211,75712,22213,538 
Gross profit Rs m1,1831,7431,7781,0131,639 
Depreciation Rs m304383457413390 
Interest Rs m4133323029 
Profit before tax Rs m9401,4611,7127741,412 
Minority Interest Rs m00000 
Prior Period Items Rs m0001-4 
Extraordinary Inc (Exp) Rs m004120-35 
Tax Rs m22832943021293 
Profit after tax Rs m7131,1321,6937541,080 
Gross profit margin %13.516.115.78.412.3 
Effective tax rate %24.322.525.12.820.7 
Net profit margin %8.110.514.96.38.1 
  BALANCE SHEET DATA
Current assets Rs m4,3944,7845,8075,6445,979 
Current liabilities Rs m2,3332,5112,3032,1182,432 
Net working cap to sales %23.521.030.929.326.6 
Current ratio x1.91.92.52.72.5 
Inventory Days Days6648666363 
Debtors Days Days7670635860 
Net fixed assets Rs m5,2125,8005,0985,3866,403 
Share capital Rs m181181181182182 
"Free" reserves Rs m6,3837,0457,9048,4249,293 
Net worth Rs m6,6067,2718,1668,6759,548 
Long term debt Rs m205209247204230 
Total assets Rs m9,86610,72511,44711,68712,843 
Interest coverage x24.045.454.726.550.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.91.01.01.01.0 
Return on assets %7.610.915.16.78.6 
Return on equity %10.815.620.78.711.3 
Return on capital %14.420.025.69.114.3 
Exports to sales %25.529.828.830.529.2 
Imports to sales %7.44.65.64.16.3 
Exports (fob) Rs m2,2363,2163,2643,6663,900 
Imports (cif) Rs m651497634499847 
Fx inflow Rs m2,3293,3513,4204,0534,356 
Fx outflow Rs m7756429198721,162 
Net fx Rs m1,5552,7082,5013,1803,194 
  CASH FLOW
From Operations Rs m 1,241 1,712 867 781 1,119 
From Investments Rs m -1,018 -1,185 357 -523 -853 
From Financial Activity Rs m -142 -514 -949 -510 -334 
Net Cashflow Rs m 81 14 275 -252 -68 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for unichem laboratories limited

 Share Holding
Indian Promoters : 50.1%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 15.1%
FIIs : 3.0%
ADR/GDR : 0.0%
Free float : 31.7%
Shareholders : 20,176
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Unichem Bhavan, Prabhat Estate, Off. S. V. Road, Jogeshwari (W), Mumbai-02
    E-MAIL: subharamank@unichemlabs.com     WEB: www.unichemlabs.com
    TELEPHONE: (022) 6688 8333     FAX: (022) 2678 4391
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Link Intime India, C-13, Pannalal Silk Mills Cmpound, LBS Marg, Mumbai-78
    AUDITOR: B. D. Jokhakar & Co.
CHM: P. A. Mody (MD) COMP SEC: K. Subharaman YEAR OF INC: 1944 BSE CODE: 506690 FV (Rs): 2 DIV YIELD (%): 0.7

More pharmaceuticals Company Fact Sheets:   WYETH LTDTORRENT PHARMAPANACEA BIOTECHALKEM LABORATORIESSUN PHARMA


Today's Market

Sensex Closes up 172 Points; Axis Bank Soars 3.3%(Closing)

Indian share markets continued to witness buying momentum in the afternoon session. At the closing bell, the BSE Sensex stood higher by 172 points, while the NSE Nifty finished up by 56 points.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why Mutual Fund Investors Should Not Worry About Market High. But...(Outside View)

Mar 22, 2017

PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.

More

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON UNICHEM LAB

UNICHEM LAB 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE UNICHEM LAB WITH

MARKET STATS